Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa

被引:146
作者
Engel, LS
Hill, JM
Caballero, AR
Green, LC
O'Callaghan, RJ
机构
[1] Louisiana State Univ, Med Ctr, Dept Microbiol Immunol & Parasitol, Ctr Eye,Sch Med, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Sch Med, Ctr Eye, Dept Ophthalmol, New Orleans, LA 70112 USA
关键词
D O I
10.1074/jbc.273.27.16792
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Comparisons of virulence between a Pseudomonas parent strain and an isogenic mutant devoid of protease TV have demonstrated a significant role for this enzyme during infection. We have characterized purified Pseudomonas aeruginosa protease TV in terms of its biochemical and enzymatic properties, and found it to be a unique extracellular protease. The N-terminal decapeptide sequence of protease IV is not homologous with any published protein sequence. Protease IV has a molecular mass of 26 kDa, an isoelectric point of 8.70, and optimum enzymatic activity at pH 10.0 and 45 degrees C. Purified protease TV demonstrates activity for the carboxyl side of lysine-containing peptides and can digest a number of biologically important proteins, including immunoglobulin, complement components, fibrinogen, and plasminogen. Protease IV is not inhibited by thiol-, carboxyl-, or metalloproteinase inhibitors. The total loss of enzyme activity in the presence of N-p-tosyl-L-chloro-methyl ketone and the partial inhibition of enzyme activity by diisopropyl fluorophosphate or phenylmethylsulfonyl fluoride imply that protease TV is a serine protease. Inhibition by dithiothreitol and beta-mercaptoethanol suggests that intramolecular disulfide bonds are essential for enzyme activity. The characteristics of this enzyme suggest that inhibitors of serine proteases could be developed into a medication designed to arrest tissue damage during Pseudomonas infection.
引用
收藏
页码:16792 / 16797
页数:6
相关论文
共 34 条
  • [1] Adams MH, 1959, BACTERIOPHAGES, P446
  • [2] AQUINO VM, 1995, PEDIATR INFECT DIS J, V14, P140
  • [3] NOSOCOMIAL PNEUMONIA - A MULTIVARIATE-ANALYSIS OF RISK AND PROGNOSIS
    CELIS, R
    TORRES, A
    GATELL, JM
    ALMELA, M
    RODRIGUEZROISIN, R
    AGUSTIVIDAL, A
    [J]. CHEST, 1988, 93 (02) : 318 - 324
  • [4] COHEN EJ, 1987, OPHTHALMOLOGY, V94, P109
  • [5] Daring G., 1993, PSEUDOMONAS AERUGINO, P245
  • [6] The use of epidemiological techniques to assess risk: The epidemiology of microbial keratitis
    Dart, JKG
    [J]. EYE, 1995, 9 : 679 - 683
  • [7] DIXON GH, 1958, J BIOL CHEM, V233, P1373
  • [8] ELLIOTT BW, 1986, J BIOL CHEM, V261, P1259
  • [9] Engel LS, 1998, INVEST OPHTH VIS SCI, V39, P662
  • [10] FLANIGAN MJ, 1994, PERITON DIALYSIS INT, V14, P248